Abstract
Purpose:
We investigate whether small incision lenticule extraction (SMILE) is associated with less ectasia than laser-assisted in-situ keratomileusis (LASIK) and whether concomitant collagen cross-linking (CXL) is protective in SMILE Xtra and LASIK Xtra.
Methods:
Using an established LASIK rabbit ectasia model, we performed −5 diopter (D) LASIK on six eyes and −5 D SMILE on six eyes; five eyes had −5 D LASIK Xtra, five eyes −5 D SMILE Xtra. Anterior segment optical coherence tomography and corneal topography were performed preoperatively and 2, 4, and 6 weeks postoperatively. Mean (standard deviation [SD]) values of postoperative keratometry (K), maximum posterior elevation (MPE) and minimum corneal thickness (CT) were compared to preoperatively and among the surgical groups (paired t-test, analysis of variance).
Results:
Mean (SD) K values decreased significantly following SMILE, SMILE Xtra, LASIK, and LASIK Xtra. The MPE increased significantly (P < 0.05) following LASIK, SMILE, and SMILE Xtra, but not following LASIK Xtra (P = 0.12). The MPE was less following SMILE than LASIK, but not statistically significant (week 2, 17.73 [5.77] vs. 22.75 [5.05] μm; P = 0.13); post-LASIK Xtra MPE was less than that following LASIK (week 2. 13.39 [3.05] vs. 22.75 [5.05] μm; P < 0.001). CT decreased significantly in all surgical groups; no differences were detected among the groups.
Conclusions:
SMILE may have less potential than LASIK to induce ectasia. LASIK Xtra and SMILE Xtra showed the smallest increase in MPE.
Translational Relevance:
Concomitant CXL may be protective following keratorefractive surgery and may reduce further the risk of ectasia.
Fourteen New Zealand white rabbits (3–4 kg body weight) were procured from the National University of Singapore and housed at Singapore Eye Research Institute, as described previously.
27–29 They were treated according to guidelines of the Association for Research in Vision and Ophthalmology's Statement for the Use of Animals in Ophthalmic and Vision Research. The study was approved by the institutional animal care and use committee of SingHealth (ref 2014/SHS/900).
The rabbits were anesthetized preoperatively and during examinations with xylazine hydrochloride (5 mg/kg intramuscularly; Troy Laboratories, Smithfield, Australia) and ketamine hydrochloride (50 mg/kg intramuscularly; Parnell Laboratories, Alexandria, Australia). At conclusion of the study, they were euthanized under anesthesia by overdose with intracardiac injection of sodium pentobarbitone (Jurox, Rutherford, Australia).
We previously established that ectasia can be induced in the rabbit cornea following −5 D LASIK treatment.
27 Using controlled laboratory conditions, we compared ectasia development between −5 D LASIK and −5 D SMILE treatments and also investigated the effect of concomitant CXL. The rabbit eyes were allocated randomly to four surgical groups. After exclusion of one rabbit that suffered corneal infection, SMILE was performed on six eyes, SMILE Xtra on five eyes, LASIK on six eyes, and LASIK Xtra on five eyes. Bilateral surgery was permitted, as LASIK and SMILE do not disrupt the animals' daily activities by causing visual disability. The rabbits were examined under anesthesia preoperatively, and 2, 4, and 6 weeks postoperatively.
The Vibex Xtra protocol was used for cases with concomitant CXL. After lenticule extraction for SMILE Xtra and excimer ablation for LASIK Xtra cases, Vibex Xtra (Avedro, Inc., Waltham, MA) 0.25% riboflavin with saline drops was applied in the pocket or the stromal bed, respectively, for 60 seconds. The excess nonabsorbed riboflavin then was rinsed off with balanced salt solution (BSS). The flap then was repositioned in LASIK Xtra cases and the wounds dried in position for LASIK Xtra and SMILE Xtra cases. Ultraviolet A (UVA) radiation was applied with the Avedro KXL system (Avedro, Inc.) with an intensity of 30 mW/cm2 for 90 seconds, delivering a total 2.7 Joules/cm2 energy. Finally, the LASIK flaps were sutured and the lids closed temporarily, as described above.
Slit-lamp photos (Righton, Tokyo, Japan) were taken preoperatively, and on day 1 and weeks 2, 4, and 6 postoperatively. They were examined for the presence of conjunctival redness, corneal infiltration, and corneal scarring.
Three anterior segment AS-OCT scans (RTVue; Optovue, Inc., Fremont, CA) were performed at each time point through the center of the cornea at the 180° axis, preoperatively and at weeks 2, 4, and 6 postoperatively. Corneal thickness (CT) was measured in the center of each AS-OCT image. The mean CT of the three measurements was calculated and then analyzed serially in the postoperative period.
ATLAS and Visante Omni (Carl Zeiss Meditec) topography were performed preoperatively and at weeks 2, 4, and 6 postoperatively. Three scans were performed each time and the mean value of the three measurements was calculated. Mean simulated keratometry (K) values, measured in D, were examined for change in the postoperative period and also compared among the four surgical groups. Astigmatism, also measured in D, was calculated from the simulated K values and examined for serial change and among the surgical groups.
The maximum posterior elevation (MPE), measured in μm, was recorded on posterior surface topography and examined for serial change with time, and compared among the four surgical groups. Minimum CT, recorded from the pachymetry maps, also was examined serially and between groups.
Data were expressed as mean ± standard deviation (SD). Data normality was assessed by Shapiro-Wilk statistics and histograms. All data showed a normal distribution; statistical comparison among different groups was performed using 1-way analysis of variance (ANOVA), paired t-tests and Bonferroni post hoc analysis. Statistical significance was P < 0.05; analysis was performed with StatPlus:mac (AnalystSoft, Inc., Walnut, CA) for Mac OS (Version v6). Comparisons among the four groups are presented consistently in the order: SMILE, SMILE Xtra, LASIK, and LASIK Xtra.
Following SMILE, MPE was significantly different between preoperatively and weeks 2, 4, and 6 (7.77 [1.48] vs. 17.73 [5.77] vs. 15.44 [8.11] vs. 18.77 [5.03] μm; P < 0.001). Bonferroni post hoc analysis compared to preoperatively showed a significant increase at week 6 (P = 0.04). Following SMILE Xtra, there also was a significant change in MPE (8.54 [1.96] vs. 14.44 [6.01] vs. 12.71 [2.38] vs. 17.76 [7.67] μm; P = 0.04). The MPE increase became significant at week 6 (P = 0.04).
A significant increase was detected following LASIK (8.09 [2.32] vs. 22.75 [5.05] vs. 19.43 [8.54] vs. 20.25 [4.70] μm; P < 0.001). Bonferroni analysis compared to preoperatively showed a significant increase at week 2 (P = 0.01). Finally, there was no significant difference following LASIK Xtra (9.34 [1.19] vs. 13.39 [3.05] vs. 14.08 [2.81] vs. 11.59 [4.57] μm; P = 0.12). Post hoc analysis did not show any significant change compared to preoperatively.
The increase in MPE following the four procedures is illustrated in
Figure 1.
There was no significant difference in MPE between SMILE and LASIK at weeks 2, 4, and 6 (P = 0.13, 0.41, and 0.60. respectively) or at any time point comparison. The MPE was significantly lower following LASIK Xtra than LASIK at weeks 2 (P < 0.001) and 6 (P = 0.01), but not at week 4 (P = 0.22); it also was significantly lower for LASIK Xtra compared to SMILE at week 6 (P = 0.03). There was no significant MPE difference between SMILE and SMILE Xtra, nor between SMILE Xtra and LASIK Xtra cases at any time point.
Following SMILE, minimum CT decreased significantly (P < 0.001); the reduction became significant at weeks 4 (Bonferroni P < 0.001) and 6 (P = 0.02).
Following SMILE Xtra, LASIK, and LASIK Xtra, minimum CT also decreased significantly (
P < 0.001); the reduction was significant at weeks 2 and 4 (week 4 Bonferroni,
P < 0.001 for SMILE Xtra, LASIK Xtra;
P ≤ 0.04 for LASIK), but borderline significant for the SMILE Xtra group at week 6 (
P = 0.11 for SMILE Xtra;
P = 0.01 for LASIK, and
P < 0.001 for LASIK Xtra). Postoperative corneal thickness change is shown in
Table 1 and
Figure 2.
There was no significant difference in preoperative minimum CT among the surgical groups (347.95 [21.70] vs. 339.12 [22.75] vs. 368.67 [27.51] vs. 341.28 [20.27] μm; P = 0.18). At week 2, there was a borderline difference in minimum CT among the groups (P = 0.07), but post hoc analysis did not show significant differences between specific groups. At weeks 4 and 6, there was no significant difference between the groups.
There was no significant difference in preoperative mean (SD) central CT among SMILE, SMILE Xtra, LASIK, and LASIK Xtra (373.19 [42.34] vs. 355.13 [21.13] vs. 388.87 [42.59] vs. 367.43 [39.23] μm;
P = 0.49). There was a significant reduction in central CT following all four surgical procedures (
P = 0.02,
P < 0.001,
P = 0.03, and
P = 0.04, respectively) (
Table 1,
Fig. 3). There was no significant difference in central CT among SMILE, SMILE Xtra, LASIK, and LASIK Xtra at weeks 2 (
P = 0.24), 4 (
P = 0.77), and 6 (311 [37.6] vs. 314.5 [34.4] vs. 340.8 [52.4] vs. 307 [36] μm;
P = 0.60).
Using an established post-LASIK ectasia model,
27 we found that SMILE and SMILE Xtra also demonstrated a significant increase in posterior surface elevation with the same −5 D myopic correction; LASIK Xtra did not. The largest elevation was observed following LASIK (22.75 μm), and the least following LASIK Xtra (14.08 μm) and SMILE Xtra (17.76 μm).
Ectasia developed in LASIK and SMILE cases; following LASIK, the MPE became significantly increased at week 2 compared to week 6 for SMILE cases. Although the difference was not statistically significant, SMILE showed a smaller MPE than LASIK (17.73 vs. 22.75 μm at week 2). This was a consistent finding at weeks 2, 4, and 6, despite preoperative corneal thickness being greater in the LASIK group (368.67 vs. 347.95 μm). The postoperative status at week 2 most likely reflects the true biomechanical weakening effect of surgery, as in this early phase the weakening effect would be expected to be decoupled from the healing response. Although the long-term effect of healing on ectasia is not known and the small number of cases may limit statistical analysis, our findings suggest that SMILE may have less potential for inducing ectasia than LASIK.
Ocular response analyzer studies have shown that corneal hysteresis, a parameter of viscous damping, and corneal resistance factor, a parameter indicative of overall viscous damping and elastic resistance, decrease following SMILE and LASIK.
18,30,31 Although no significant postoperative difference has been shown between SMILE and LASIK,
30 two studies have found a greater decrease in corneal hysteresis and corneal resistance factor following LASIK than SMILE for cases with a spherical equivalent greater than −6 D.
18,31 A further study showed that the percentage reduction in corneal hysteresis and corneal resistance factor was greater following LASIK than SMILE.
17 These studies suggest a biomechanical advantage to SMILE, which could translate into a smaller ectasia risk, as found in our rabbit study.
Postoperative deformation amplitude and applanation time, measured with dynamic high-speed Scheimpflug imaging, have been shown not to be different between the two procedures,
19,32 although increased and reduced, respectively, following SMILE and LASIK.
32,33 Shetty et al.,
33 in support of a preferential biomechanical recovery or healing response for SMILE, found that corneal deformation with higher forces returned to near preoperative levels by month 6 following SMILE, but not following LASIK. In addition, Mastropasqua et al.
34 found no significant postoperative change in deformation amplitude and applanation time 30 and 90 days following SMILE. A biomechanical advantage may be inferred for SMILE performed on healthy corneas; however, reports of post-SMILE ectasia have shown that a biomechanically weak cornea, such as in forme fruste or manifest keratoconus, can suffer ectasia.
20,21
LASIK Xtra cases consistently maintained a significantly lower MPE than LASIK cases. Although SMILE Xtra cases also showed a lower MPE than SMILE at all time points, the difference was not significant. The small number of study cases may be a contributing factor, potentially unmasking small inherent differences in corneal elasticity among the groups. Thus, concomitant CXL may reduce the risk of post-keratorefractive surgery ectasia, due to a biomechanical stabilizing effect on the cornea. This stabilizing effect was similarly manifest in LASIK Xtra and SMILE Xtra from week 2 postoperatively and up to week 4. At week 6, the SMILE Xtra group had an increase in MPE that was not significantly different to LASIK Xtra. However, as our study aimed to induce ectasia and was time-limited in follow-up, the long-term biomechanical benefit of concomitant CXL cannot be presumed. Clinical studies on LASIK Xtra and SMILE Xtra have been promising. In a randomized comparison study, unaided and corrected visual acuities at 6 months were identical in LASIK and LASIK Xtra, although 4.16% of cases in the LASIK Xtra group lost one or more lines of corrected distance visual acuity (CDVA) due to haze.
35 Two independent studies, however, have shown that LASIK Xtra was not associated with visual loss.
24,26 Similarly for SMILE Xtra, one study found that 33% of cases lost 1 line of CDVA at 6 months,
36 whereas Ganesh et al.
25 showed no loss of CDVA at 12 months. Larger prospective studies are required to investigate the effect of concomitant CXL on vision, safety and refractive outcomes. Our findings, however, suggested that biomechanically it has an important stabilizing effect on the cornea.
Corneal thickness decreased significantly in the postoperative period for all procedures, as removal of the lenticule in SMILE and excimer ablation in LASIK result in tissue loss. The SMILE Xtra and LASIK Xtra groups had a lower postoperative corneal thickness than the SMILE and LASIK groups, respectively. It is well documented that CXL is associated with an immediate postoperative reduction in corneal thickness and a gradual return toward baseline in the subsequent 3 to 12 months.
12 Stromal compaction, dehydration, or epithelial changes may account for this.
37
Confocal microscopy showed that the interface of all four procedures was hypocellular and with similar levels of increased reflectivity 2 weeks postoperatively. LASIK Xtra, and to an extent SMILE Xtra, had less keratocytes than standard LASIK and SMILE 50 to 60 μm deep to the interface, most likely due to the apoptotic effect of CXL on keratocytes; this may account for the lowest posterior stromal reflectivity observed following LASIK Xtra. We found that SMILE had less anterior stromal reflectivity than LASIK and LASIK Xtra. SMILE has been shown, with IVCM and immunohistochemistry, to induce less stromal inflammation than LASIK.
38 LASIK Xtra and SMILE Xtra have not been studied in detail with IVCM; however a hypocellular interface and keratocyte apoptosis to a depth of 60 μm below the interface have been found following LASIK Xtra and SMILE Xtra.
39,40
In conclusion, to our knowledge this is the first study to show that, for the same myopic refractive correction, SMILE may have less potential than LASIK to induce ectasia. Concomitant CXL in this biological animal model had a protective effect, as LASIK Xtra cases showed the least potential for ectasia. Combined with the novelty of the procedure, this exciting finding advocates further clinical research to investigate the refractive effect, haze development, and safety of LASIK and SMILE when combined with CXL.
Supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme (NMRC/TCR/008-SERI/2013) and administered by the Singapore Ministry of Health's National Medical Research Council.
Disclosure: A. Konstantopoulos, None; Y.-C. Liu, None; E.P. Teo, None; C.L. Nyein, None; G.H. Yam, None; J.S. Mehta, None